UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 430

Sortiert nach

Lessons for modern insulin development

Diabetic medicine, 2018-10, Vol.35 (10), p.1320-1328

2018

Volltextzugriff (PDF)

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies

Diabetes, obesity & metabolism, 2009-12, Vol.11 (s3), p.26-34

2009

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293-1297

2013

Volltextzugriff (PDF)

USA joins Canada, UK, Ireland and Austria in allowing people with insulin‐treated diabetes to fly commercial aircraft

Diabetic medicine, 2020-07, Vol.37 (7), p.1202-1203

2020

Volltextzugriff (PDF)

Hepatoselectivity and the evolution of insulin

Diabetes, obesity & metabolism, 2014-01, Vol.16 (1), p.1-8

2014

Volltextzugriff (PDF)

SGLT2 inhibitors in Type 1 diabetes: is this the future?

Diabetic medicine, 2018-12, Vol.35 (12), p.1642-1643

2018

Volltextzugriff (PDF)

Hepato-preferential insulins: Is this the end, or the end of the beginning?

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1053-1054

Russell-Jones, D. L.

2016

Volltextzugriff (PDF)

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review

Diabetes, obesity & metabolism, 2013-11, Vol.15 (11), p.978-986

2013

Volltextzugriff (PDF)

Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial

Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1055-1064

2016

Volltextzugriff (PDF)

Is insulin the most effective injectable antihyperglycaemic therapy?

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.145-151

2015

Volltextzugriff (PDF)

A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes

Diabetic medicine, 2020-02, Vol.37 (2), p.219-228

2020

Volltextzugriff (PDF)

Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK

Diabetes, obesity & metabolism, 2016-12, Vol.18 (12), p.1157-1166

2016

Volltextzugriff (PDF)

Miscoding, misclassification and misdiagnosis of diabetes in primary care

Diabetic medicine, 2012-02, Vol.29 (2), p.181-189

2012

Volltextzugriff (PDF)

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Diabetes, obesity & metabolism, 2013-01, Vol.15 (1), p.42-54

2013

Volltextzugriff (PDF)

Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?

Diabetes, obesity & metabolism, 2015-10, Vol.17 (10), p.919-927

2015

Volltextzugriff (PDF)

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials

Nutrition, metabolism, and cardiovascular diseases, 2015-10, Vol.25 (10), p.898-905

2015

Volltextzugriff (PDF)

The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes

International journal of clinical practice (Esher), 2010-09, Vol.64 (10), p.1402-1414

Russell-Jones, D.

2010

Volltextzugriff (PDF)

Insulin analogues: an example of applied medical science

Diabetes, obesity & metabolism, 2009, Vol.11 (1), p.5-19

2009

Volltextzugriff (PDF)

Insulin analogues and cancer risk: cause for concern or cause célèbre?

International journal of clinical practice (Esher), 2010-04, Vol.64 (5), p.628-636

2010

Volltextzugriff (PDF)

Can an interprofessional education tool improve healthcare professional confidence, knowledge and quality of inpatient diabetes care: a pilot study?

Diabetic medicine, 2013-07, Vol.30 (7), p.864-870

2013

Volltextzugriff (PDF)

L’insuline asparte ultra-rapide vs insuline asparte en prandiale améliore le contrôle glycémique chez les patients DT1 : étude onset® 1

Annales d'endocrinologie, 2016-09, Vol.77 (4), p.268-269

2016

Volltextzugriff (PDF)

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Diabetologia, 2009-10, Vol.52 (10), p.2046-2055

2009

Volltextzugriff (PDF)

Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes

Diabetes, obesity & metabolism, 2015-05, Vol.17 (5), p.459-467

2015

Volltextzugriff (PDF)

Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes

Diabetes, obesity & metabolism, 2015-11, Vol.17 (11), p.1100-1103

2015

Volltextzugriff (PDF)

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

Diabetologia, 2005-03, Vol.48 (3), p.420-426

2005

Volltextzugriff (PDF)

1 – 25 von 430

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(384)
Mit Volltextzugriff
(390)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(267)
Life Sciences & Biomedicine
(240)
Humans
(193)
Biological And Medical Sciences
(137)
Male
(111)
Medical Sciences
(108)
Female
(107)
Endocrinology & Metabolism
(100)
Adult
(87)
Middle Aged
(73)
Animals
(54)
Fundamental And Applied Biological Sciences. Psychology
(44)
Aged
(39)
Diabetes
(34)
Endocrinopathies
(33)
Pharmacology. Drug Treatments
(27)
Mice
(26)
Dermatology
(24)
Insulin
(24)
Diabetes Mellitus, Type 1 - Drug Therapy
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lessons for modern insulin development

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

USA joins Canada, UK, Ireland and Austria in allowing people with insulin‐treated diabetes to fly commercial aircraft

Hepatoselectivity and the evolution of insulin

SGLT2 inhibitors in Type 1 diabetes: is this the future?

Hepato-preferential insulins: Is this the end, or the end of the beginning?

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review

Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial

Is insulin the most effective injectable antihyperglycaemic therapy?

A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes

Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK

Miscoding, misclassification and misdiagnosis of diabetes in primary care

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials

The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes

Insulin analogues: an example of applied medical science

Insulin analogues and cancer risk: cause for concern or cause célèbre?

Can an interprofessional education tool improve healthcare professional confidence, knowledge and quality of inpatient diabetes care: a pilot study?

L’insuline asparte ultra-rapide vs insuline asparte en prandiale améliore le contrôle glycémique chez les patients DT1 : étude onset® 1

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes

Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

Suchergebnisse filtern